2020
DOI: 10.1002/pbc.28485
|View full text |Cite
|
Sign up to set email alerts
|

COVID‐19 anticoagulation recommendations in children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
68
0
6

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 61 publications
(75 citation statements)
references
References 16 publications
1
68
0
6
Order By: Relevance
“…Recently published anticoagulation recommendations for children support the evaluation of children with SARS-CoV-2 infection for thrombosis, not only at admission but daily during hospitalization. 55 Because of the multiple risk factors, administration of prophylactic anticoagulant therapy for children is recommended only after careful consideration of each child's bleeding risk. 55 COVID-19 may cause disseminated intravascular coagulation in adult patients, with a mild decrease in platelet count and mild prolongation of partial thromboplastin time, but no signs of microangiopathy.…”
Section: The Risk Of Thrombotic Complications In Children With Covid-19mentioning
confidence: 99%
See 2 more Smart Citations
“…Recently published anticoagulation recommendations for children support the evaluation of children with SARS-CoV-2 infection for thrombosis, not only at admission but daily during hospitalization. 55 Because of the multiple risk factors, administration of prophylactic anticoagulant therapy for children is recommended only after careful consideration of each child's bleeding risk. 55 COVID-19 may cause disseminated intravascular coagulation in adult patients, with a mild decrease in platelet count and mild prolongation of partial thromboplastin time, but no signs of microangiopathy.…”
Section: The Risk Of Thrombotic Complications In Children With Covid-19mentioning
confidence: 99%
“…55 Because of the multiple risk factors, administration of prophylactic anticoagulant therapy for children is recommended only after careful consideration of each child's bleeding risk. 55 COVID-19 may cause disseminated intravascular coagulation in adult patients, with a mild decrease in platelet count and mild prolongation of partial thromboplastin time, but no signs of microangiopathy. 55 Meta-analysis of 551 pediatric cases showed that the prevalence of raised D-dimers was 12%, but there was no mention of thrombotic adverse events in the children.…”
Section: The Risk Of Thrombotic Complications In Children With Covid-19mentioning
confidence: 99%
See 1 more Smart Citation
“…Major hematology organizations, including the American Society of Hematology (ASH) 8 and the International Society of Thrombosis Haemostasis (ISTH) 9 have published recommendations for anticoagulation of hospitalized symptomatic adults with SARS-CoV-2, which have been largely extrapolated to the pediatric population. A recent report by Loi et al 10 has made some diagnostic and therapeutic anticoagulation recommendations based on risk stratification of a single institutional experience. However, there remains a need in this population for laboratory-based risk-assessment tools to guide clinical decision making on the use of anticoagulant prophylaxis.…”
Section: Introductionmentioning
confidence: 99%
“…The awareness of VTE association with COVID-19 has led to recommendations by the International Society of Thrombosis Hemostasis and others to consider prophylactic anticoagulation for hospitalized adults with COVID-19 (Spyropoulos et al, 2020). Similar recommendations for pediatric populations are being developed (Loi et al, 2020). These include labo- Prophylactic anticoagulation with LMWH has previously been shown to prevent thrombosis in at risk hospitalized adults (Dentali et al, 2007).…”
Section: To the Editormentioning
confidence: 99%